The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market analysis, indiv ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

For a limited time, Amazon is offering up to 40% off Shark's cutting-edge vacuums, mops, air purifiers and even a top-rated ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in startups focused on pain management and treatment. Turns out there’s quite a ...

AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...

The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.

Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for ...